Langone Projected Eli Lilly Share Price of $2,000
The investor signaled long-term confidence in the pharma giant as he discussed faith in business.
Updated on Sept. 29, 2026 in Healthcare
Live Poll
Do you believe personal values and faith should guide decisions in the business world?
Kenneth Langone, co-founder of The Home Depot and a major investor in Eli Lilly and Co., predicted the latter's share price would reach $2,000 within the next three to four years. He shared the forecast while speaking at The Catholic Center at NYU regarding the role of character in professional life.
Why it matters
Langone's outlook provides a notable signal for market participants monitoring the pharmaceutical sector, given his history as a long-term shareholder since 1977. His perspective highlights how high-net-worth operators balance institutional philanthropy with long-term portfolio convictions.
Langone, who holds a net worth of approximately $10 billion, has been invested in Eli Lilly and Co. since 1977. His projection for the stock price comes amid his continued support for medical institutions, including $400 million in total donations to NYU-affiliated health centers.
The players
Kenneth Langone
A billionaire investor and co-founder of the retail giant The Home Depot who maintains significant positions in healthcare equities.
Eli Lilly and Co.
A global pharmaceutical company and a major holding in Langone's investment portfolio.
The Home Depot
A massive home improvement retailer currently valued at nearly $300 billion.
Fr. Cassian Derbes
The moderator of the fireside chat held at the academic venue.
The details
The comments were made during a fireside chat moderated by Fr. Cassian Derbes before an audience of approximately 100 people. Langone also touched on his early career, referencing his 1957 economics degree from Bucknell University. Outside the event, demonstrators distributed flyers criticizing the proceedings, providing a counter-narrative to the business-focused discussion.
Timeline
September 28, 2026: Kenneth Langone spoke at The Catholic Center at NYU.
1977: Langone began his long-term position in Eli Lilly and Co. stock.
2023: Langone completed a $200 million donation to NYU Langone Health.
2008: Langone made a $200 million donation to NYU Medical Center.
1957: Langone graduated from Bucknell University with an economics degree.
Market Landscape
This appearance extends Langone's pattern of public discourse regarding the intersection of institutional leadership and personal values. It follows his significant 2023 donation to NYU Langone Health, anchoring his current market commentary within his broader role as a major medical donor.
Operators tracking pharmaceutical sector performance should factor this long-term price target into their evaluation of sentiment among institutional healthcare investors. Monitor the upcoming quarterly filings for Eli Lilly and Co. to assess how actual performance trends against the public forecast.
The takeaway
The interaction demonstrates how high-profile investors use public forums to reinforce long-term confidence in specific market equities. Monitor pharmaceutical sector analyst reports over the coming quarters to see if institutional consensus shifts toward Langone's bullish outlook.
Further reading
For broader trends in the industry, see our coverage of Healthcare.
Source note: This article includes information reported by Washington Square News.
Live Poll
Do you believe personal values and faith should guide decisions in the business world?
